Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VANI Vivani Medical, Inc.

Market Closed 04-26 16:00:00 EDT

1.63

-0.06

-3.83%

盘后1.61

-0.02-1.23%

19:50 EDT

High1.70	Low1.62	Vol116.96K
Open1.70	D1 Closing1.70	Amplitude4.72%
Mkt Cap89.61M	Tradable Cap49.97M	Total Shares54.98M
T/O192.79K	T/O Rate0.38%	Tradable Shares30.66M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"VANI","market":"US","secType":"STK","nameCN":"Vivani Medical, Inc.","latestPrice":1.63,"timestamp":1714161600000,"preClose":1.695,"halted":0,"volume":116955,"hourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.63,"latestTime":"19:50 EDT","volume":7270,"amount":11784.796,"timestamp":1714175441619},"delay":0,"floatShares":30659278,"shares":54978000,"eps":-0.504434,"marketStatus":"Market Closed","change":-0.065,"latestTime":"04-26 16:00:00 EDT","open":1.7,"high":1.7,"low":1.62,"amount":192787.55770950002,"amplitude":0.047198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.504434,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1714377600000},"marketStatusCode":7,"adr":0,"listingDate":1416373200000,"exchange":"NASDAQ","adjPreClose":1.695,"preHourTrading":{"tag":"盘前","latestPrice":1.6804,"preClose":1.695,"latestTime":"09:01 EDT","volume":271,"amount":457.66580270000003,"timestamp":1714136469916},"postHourTrading":{"tag":"盘后","latestPrice":1.61,"preClose":1.63,"latestTime":"19:50 EDT","volume":7270,"amount":11784.796,"timestamp":1714175441619},"volumeRatio":1.0348928372312218},"requestUrl":"/m/hq/s/VANI","defaultTab":"news","newsList":[{"id":"2429490739","title":"Vivani Medical files for $300M mixed shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2429490739","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429490739?lang=en_us&edition=fundamental","pubTime":"2024-04-23 06:03","pubTimestamp":1713823390,"startTime":"0","endTime":"0","summary":"Vivani Medical  disclosed in an SEC filing on Monday after the bell a prospectus to offer and sell common stock, preferred stock, debt securities, warrants, units to raise $300 million.More on Vivani Medical  Vivani Medical surges after animal data on obesity implants Seeking Alpha’s Quant Rating on Vivani Medical Historical earnings data for Vivani Medical Financial information for Vivani Medical","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4092244-vivani-medical-files-for-300m-mixed-shelf","is_publish_highlight":false,"gpt_icon":0},{"id":"2429902514","title":"BRIEF-Vivani Medical Files For Mixed Shelf Of Up To $300 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2429902514","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2429902514?lang=en_us&edition=fundamental","pubTime":"2024-04-23 05:54","pubTimestamp":1713822870,"startTime":"0","endTime":"0","summary":"April 22  - Vivani Medical Inc   :   * VIVANI MEDICAL INC FILES FOR MIXED SHELF OF UP TO $300 MILLION – SEC FILING   * VIVANI MEDICAL- SALES AGREEMENT PROSPECTUS COVERING OFFERING UP TO $75 MILLION COMMON STOCK THAT MAY BE ISSUED FROM TIME TO TIMEFurther company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422138124","title":"Vivani Medical: A Growth-Focused Gamble with No Dividend Payouts in Sight","url":"https://stock-news.laohu8.com/highlight/detail?id=2422138124","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2422138124?lang=en_us&edition=fundamental","pubTime":"2024-03-28 14:01","pubTimestamp":1711605671,"startTime":"0","endTime":"0","summary":"Vivani Medical, Inc. (VANI) has disclosed a new risk, in the Accounting & Financial Operations category. Vivani Medical, Inc. presents a significan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivani-medical-a-growth-focused-gamble-with-no-dividend-payouts-in-sight?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivani-medical-a-growth-focused-gamble-with-no-dividend-payouts-in-sight?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2422605566","title":"Vivani Medical Inc (VANI) Reports Fourth Quarter and Full Year 2023 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2422605566","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2422605566?lang=en_us&edition=fundamental","pubTime":"2024-03-27 09:02","pubTimestamp":1711501340,"startTime":"0","endTime":"0","summary":"Net Loss: Q4 net loss of $6.0 million, a decrease from $7.3 million in Q4 2022, aligning closely with analyst projections.Research and Development Expenses: Increased to $4.7 million in Q4 2023 from $4.4 million in Q4 2022, reflecting strategic focus on obesity portfolio.General and Administrative Expenses: Decreased to $1.5 million in Q4 2023 from $3.4 million in Q4 2022, due to a prior legal claim provision.Vivani Medical Inc , a preclinical stage biopharmaceutical company, released its 8-K filing on March 26, 2024, detailing its fourth quarter and full year financial results for 2023. The company, known for developing miniaturized, subdermal implants utilizing its proprietary NanoPortal technology, reported a net loss of $6.0 million for the fourth quarter, which closely aligns with the estimated loss of $7.318 million projected by analysts. The full year net loss amounted to $25.7 million, a significant increase from the previous year's $13.9 million. This financial performance ref","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vivani-medical-inc-vani-reports-010220840.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2422614998","title":"Vivani Medical Inc reports results for the quarter ended in December - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2422614998","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2422614998?lang=en_us&edition=fundamental","pubTime":"2024-03-26 22:34","pubTimestamp":1711463672,"startTime":"0","endTime":"0","summary":"* Vivani Medical Inc    reported a quarterly adjusted loss of 12 cents per share for the quarter ended in December.  The lone analyst forecast for the quarter was for a loss of 14 cents per share.    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422692750","title":"Vivani Medical Updates Investors with Informative Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2422692750","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2422692750?lang=en_us&edition=fundamental","pubTime":"2024-03-26 20:42","pubTimestamp":1711456962,"startTime":"0","endTime":"0","summary":"Vivani Medical (VANI) just unveiled an announcement. The Company regularly shares informative slide presentations with the investment community at ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivani-medical-updates-investors-with-informative-presentations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivani-medical-updates-investors-with-informative-presentations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2422769203","title":"Vivani Medical GAAP EPS of -$0.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2422769203","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2422769203?lang=en_us&edition=fundamental","pubTime":"2024-03-26 20:38","pubTimestamp":1711456714,"startTime":"0","endTime":"0","summary":"Vivani Medical press release  : Q4  GAAP EPS of -$0.12.As of December 31, 2023, Vivani had cash, cash equivalents and restricted cash totaling $22.0 million, compared to $46.4 million as of December 31, 2022.More on Vivani Medical  Vivani Medical surges after animal data on obesity implants Seeking Alpha’s Quant Rating on Vivani Medical Historical earnings data for Vivani Medical Financial information for Vivani Medical","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4083665-vivani-medical-gaap-eps-of-0_12","is_publish_highlight":false,"gpt_icon":0},{"id":"2422869266","title":"Vivani Medical Q4 EPS $(0.12) Beats $(0.14) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2422869266","media":"Benzinga","top":-1,"share":"https://ttm.financial/m/news/2422869266?lang=en_us&edition=fundamental","pubTime":"2024-03-26 20:32","pubTimestamp":1711456355,"startTime":"0","endTime":"0","summary":"Vivani Medical (NASDAQ:VANI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 33.33 percent increase over losses of $(0.18) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/03/37932342/vivani-medical-q4-eps-0-12-beats-0-14-estimate","is_publish_highlight":false,"gpt_icon":0},{"id":"2422692372","title":"Press Release: Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2422692372","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2422692372?lang=en_us&edition=fundamental","pubTime":"2024-03-26 20:30","pubTimestamp":1711456200,"startTime":"0","endTime":"0","summary":"Strategic shift prioritizes the development of GLP-1 implants for the treatment of obesity and chronic weight management. Positive NPM-115  preclinical weight loss data comparable to semaglutide, active ingredient in Ozempic /Wegovy. $15 million financing round enables acceleration of priority development programs and secures operations into the second half of 2025. Vivani Medical, Inc.  , a biopharmaceutical company developing miniaturized, long-term drug implants including its lead asset NPM-115 for chronic weight management in obese or overweight patients with one or more risk factors, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update.In March 2024, Vivani announced the pricing of a $15 million registered direct offering of common stock and warrants. Proceeds from the financing will enable acceleration of priority development programs, including NPM-115 for obesity, and provides funding of operations into th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2421204098","title":"Vivani Medical Inc    expected to post a loss of 14 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2421204098","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2421204098?lang=en_us&edition=fundamental","pubTime":"2024-03-23 04:55","pubTimestamp":1711140908,"startTime":"0","endTime":"0","summary":"* Vivani Medical Inc     is expected to report resultson March 25 (estimated) for the period ending December 31 2023   *    * LSEG's mean analyst estimate for Vivani Medical Inc is for a loss of 14 ce","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417768984","title":"Maxim Group Sticks to Its Buy Rating for Vivani Medical (VANI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2417768984","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2417768984?lang=en_us&edition=fundamental","pubTime":"2024-03-07 20:38","pubTimestamp":1709815128,"startTime":"0","endTime":"0","summary":"Maxim Group analyst Naz Rahman maintained a Buy rating on Vivani Medical (VANI – Research Report) yesterday. The company’s shares closed yesterday ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-vivani-medical-vani?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-its-buy-rating-for-vivani-medical-vani?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2417487294","title":"BUZZ-Vivani Medical rises after appointing former Amylin Pharmaceuticals CEO to its board","url":"https://stock-news.laohu8.com/highlight/detail?id=2417487294","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2417487294?lang=en_us&edition=fundamental","pubTime":"2024-03-06 22:26","pubTimestamp":1709735199,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Vivani Medical    rise 4.2% to $2.24 premarket    ** VANI appoints former CEO of Amylin Pharmaceuticals, Daniel Bradbury, to its Board of Directors   ** Bradbury headed Amylin Pharmaceuticals until its acquisition by Bristol-Myers Squibb    in 2012     ** Appointment comes as VANI prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management    ** Co last month said that its experimental under-the-skin drug implant helped reduce weight in obese mice in a pre-clinical trial, sending its shares up more than five-fold    ** Up to last close, stock has risen 97.2% in the last 12 months  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417918832","title":"Vivani Medical Expands Board, Appoints Pharma Veteran Bradbury","url":"https://stock-news.laohu8.com/highlight/detail?id=2417918832","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2417918832?lang=en_us&edition=fundamental","pubTime":"2024-03-06 21:42","pubTimestamp":1709732558,"startTime":"0","endTime":"0","summary":"An announcement from Vivani Medical (VANI) is now available. Vivani Medical, Inc. has expanded its Board of Directors from five to six members and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vivani-medical-expands-board-appoints-pharma-veteran-bradbury?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vivani-medical-expands-board-appoints-pharma-veteran-bradbury?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2417766298","title":"BRIEF-Vivani Medical Appoints Daniel Bradbury To Its Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2417766298","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2417766298?lang=en_us&edition=fundamental","pubTime":"2024-03-06 21:04","pubTimestamp":1709730289,"startTime":"0","endTime":"0","summary":"March 6  - Vivani Medical Inc   :   * VIVANI MEDICAL APPOINTS DANIEL BRADBURY TO ITS BOARD OF DIRECTORS   * VIVANI MEDICAL INC - APPOINTMENT COMES AS VIVANI PRIORITIZES DEVELOPMENT OF ITS GLP-1 IMPLANTS FOR TREATMENT OF OBESITY AND CHRONIC WEIGHT MANAGEMENTSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417968462","title":"Vivani Medical Appoints Daniel Bradbury to its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2417968462","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2417968462?lang=en_us&edition=fundamental","pubTime":"2024-03-06 21:00","pubTimestamp":1709730000,"startTime":"0","endTime":"0","summary":"Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management. Under Bradbury’s leadership as CEO, Amylin Pharmaceuticals, with partner Alkermes, secured in 2012 approval of Bydureon , the world’s first once-weekly GLP-1 receptor agonist, a class of drugs that now includes blockbusters Ozempic, Trulicity, and Wegovy. ALAMEDA, Calif., March 06, 2024----Vivani Medical, Inc.  , an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced the appointment of long-time industry veteran Daniel Bradbury to its Board of Directors.Leveraging its proprietary NanoPortal platform, Vivani Medical develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve medication tolerability. Vivani’s lead programs NPM-115 and NPM-119 are miniature, six-month, GLP-1 ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/VpcO9T_pdCbCShuRyrOvJg--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ce26a674a16a8319ce8ff967179bae58","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/VpcO9T_pdCbCShuRyrOvJg--~B/aD00ODA7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/ce26a674a16a8319ce8ff967179bae58"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vivani-medical-appoints-daniel-bradbury-130000248.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2417127532","title":"JAGX, BBAI and BNTC among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2417127532","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2417127532?lang=en_us&edition=fundamental","pubTime":"2024-03-05 01:35","pubTimestamp":1709573730,"startTime":"0","endTime":"0","summary":"Gainers:Phunware (PHUN) +133%.Ocean Biomedical (OCEA) +57%.Jaguar Health (JAGX) +54%.Energem Corp (ENCP) +47%.Ainos (AIMD) +41%.Renalytix (RNLX) +38%.Xos (XOS) +35%.BigBear.ai Holdings (BBAI) +30%.Urgent.ly (ULY) +30%.Losers: BioVie (BIVI) -42%.Astra Space (ASTR) -39%.Bit Origin Ltd (BTOG) -28%.Minim (MINM) -24%.Infobird Co Ltd (IFBD) -24%.Vivani Medical (VANI) -20%.Beamr Imaging Ltd (BMR) -19%.First Wave BioPharma (FWBI) -18%.Cardio Diagnostics Holdings (CDIO) -17%.Benitec Biopharma (BNTC) -18%.","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4075475-jagx-bbai-and-bntc-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2416012624","title":"MTC , ENCP and MINM among mid-day movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2416012624","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2416012624?lang=en_us&edition=fundamental","pubTime":"2024-03-02 01:50","pubTimestamp":1709315441,"startTime":"0","endTime":"0","summary":"Gainers: Mmtec (MTC) +115%.BioVie (BIVI) +54%.Adial Pharmaceuticals (ADIL) +52%.Xponential Fitness (XPOF) +44%.Therealreal (REAL) +40%.Minim (MINM) +35%.Cardiff Oncology (CRDF) +31%.Sweetgreen (SG) +29%.Root (ROOT) +29%.Dell Technologies (DELL) +28%.Losers: GigCapital5 (GIA) -61%.Esgen Acquisition Corp (ESAC) -42%.Fisker (FSR) -39%.Scilex Holding Company (SCLX) -36%.Sidus Space (SIDU) -35%.Precision Biosciences (DTIL) -34%.Energem Corp (ENCP) -33%.DermTech (DMTK) -34%.Vivani Medical (VANI) -25%.Jakks Pacific (JAKK) -26%.","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215119911/image_1215119911.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4074788-mtc-encp-and-minm-among-mid-day-movers","is_publish_highlight":false,"gpt_icon":0},{"id":"2416964471","title":"Vivani Medical Shares Retreat 20% on Securities Purchase Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2416964471","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2416964471?lang=en_us&edition=fundamental","pubTime":"2024-03-01 23:03","pubTimestamp":1709305380,"startTime":"0","endTime":"0","summary":"Vivani Medical shares retreated 20% to $3.37 following a securities purchase agreement with an institutional investor.The stock has nearly tripled over the last 12 months.The preclinical-stage biopharmaceutical company said the agreement is for the purchase of about 3.9 million shares of common stock and warrants to purchase up to an aggregate of 3.9 million shares of common stock at a purchase price of $3.80 a share.Vivani expects gross proceeds around $15 million before fees and other expenses. The offering is expected to close on or about Tuesday.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2416645630","title":"LVTX, VIEW and LASE among pre-market losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2416645630","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2416645630?lang=en_us&edition=fundamental","pubTime":"2024-03-01 21:37","pubTimestamp":1709300275,"startTime":"0","endTime":"0","summary":"Losers: GigCapital5 (GIA) -60% announces closing date for business combination with QT imaging. Scilex Holding Company (SCLX) -33% to raise $10M via bough deal offering. Sidus Space (SIDU) -32% on pri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4074529-lvtx-view-and-lase-among-pre-market-losers","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivani.com","stockEarnings":[{"period":"1week","weight":-0.0412},{"period":"1month","weight":-0.1189},{"period":"3month","weight":0.5825},{"period":"6month","weight":0.5234},{"period":"1year","weight":0.4052},{"period":"ytd","weight":0.598}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.032108},{"month":2,"riseRate":0.4,"avgChangeRate":0.333362},{"month":3,"riseRate":0.4,"avgChangeRate":0.230776},{"month":4,"riseRate":0.4,"avgChangeRate":0.006663},{"month":5,"riseRate":0.444444,"avgChangeRate":0.031924},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.040698},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.029205},{"month":8,"riseRate":0.222222,"avgChangeRate":-0.125452},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.061449},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.120273},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.070385},{"month":12,"riseRate":0.4,"avgChangeRate":0.042919}],"exchange":"NASDAQ","name":"Vivani Medical, Inc.","nameEN":"Vivani Medical, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vivani Medical, Inc.,VANI,Vivani Medical, Inc.股票,Vivani Medical, Inc.股票老虎,Vivani Medical, Inc.股票老虎国际,Vivani Medical, Inc.行情,Vivani Medical, Inc.股票行情,Vivani Medical, Inc.股价,Vivani Medical, Inc.股市,Vivani Medical, Inc.股票价格,Vivani Medical, Inc.股票交易,Vivani Medical, Inc.股票购买,Vivani Medical, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vivani Medical, Inc.(VANI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vivani Medical, Inc.(VANI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction